CNR Institutional Research Information System

GHIGNA, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 325
AS - Asia 83
EU - Europa 32
Totale 440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 319
SG - Singapore 83
IT - Italia 18
CA - Canada 6
DE - Germania 6
GB - Regno Unito 4
FI - Finlandia 3
NL - Olanda 1
Totale 440
Salva come PNG Salva come JPEG
Città #
Santa Clara 296
Singapore 62
Pavia 8
Milan 6
Toronto 5
Falkenstein 4
London 4
Helsinki 3
Farra d'Alpago 2
Frankfurt am Main 2
Phoenix 2
Forest City 1
Ottawa 1
Seattle 1
Totale 397
Salva come PNG Salva come JPEG
Nome #
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer 18
Clinical Significance and Regulation of ERK5 Expression and Function in Cancer 15
Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene 14
Alternative splicing in Alzheimer's disease 13
ASF/SF2 regola lo splicing alternativo del proto-oncogene Ron e induce mobilità cellulare 12
Global alternative splicing defects in human breast cancer cells 12
Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis 12
Cell motility and alternative splicing of the Ron oncogene are controlled by SF2/ASF 11
Identification of bi-allelic LFNG variants in three patients and further clinical and molecular refinement of spondylocostal dysostosis 3 11
RNA recognition motif 2 directs the recruitment of SF2/ASF to nuclear stress bodies. 11
Transcription of Satellite III non-coding RNAs is a general stress response in human cells 11
Alternative splicing of tumor suppressors and oncogenes. 11
Opposite Roles of Tra2 beta and SRSF9 in the v10 Exon Splicing of CD44 11
Cell motility and alternative splicing of the Ron oncogene are controlled by SF2/ASF 10
Alternative Splicing of Tumor Suppressors and Oncogenes 10
A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis 10
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. 10
Growth-dependent and growth-independent translation of messengers for heterogeneous nuclear ribonucleoproteins. 10
Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT). 9
The alternative splicing factor Nova2 regulates vascular development and lumen formation. 9
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer. 9
Alternative splicing and cancer: A stressing game? 9
Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: Therapeutic potential of bifunctional oligonucleotides and indole derivatives 9
SRSF9 Regulates Cassette Exon Splicing of Caspase-2 by Interacting with Its Downstream Exon 9
The alternative splicing side of cancer 9
Alternative pre-mRNA processing in cancer progression: clinical significance and therapeutic implications 9
Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. 8
EMT and stemness: Flexible processes tuned by alternative splicing in development and cancer progression 8
Sam68 regulates epithelial to mesenchymal transition through alternative splicing- activated NMD of the SF2/ASF proto-oncogene. 8
Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA 8
Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer 8
HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition. 8
Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy. 8
Alternative Splicing: Recent Insights into Mechanisms and Functional Roles 8
Splicing Factor SF2/ASF at the crossroad between cell proliferation, differentiation and the DNA damage response. 7
The complex connection between alternative splicing and the epithelial to mesenchymal cell transition 7
Regulation of splicing factor SF2/ASF in response to proliferation, differentiation and DNA damage 7
Posttranscriptional Regulation and RNA Binding Proteins in Cancer Biology. 7
hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron 6
Alternative splicing: role in cancer development and progression. 6
Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells 6
SAM68: Signal Transduction and RNA Metabolism in Human Cancer 6
A 2-nt RNA enhancer on exon 11 promotes exon 11 inclusion of the Ron proto-oncogene 6
Heterogeneous nuclear ribonucleoproteins (hnRNPs): an emerging family of autoantigens in rheumatic diseases. 6
SF2/ASF regola lo splicing alternativo del proto-oncogene Ron e induce mobilità cellulare 6
Post-transcriptional regulation of EMT: lessons from the Ron proto-oncogene 6
Alternative splicing and tumor progression. (Review) 6
Diversification of the muscle proteome through alternative splicing 6
Ultraconserved DNA elements, alternative splicing and cell identity 5
Alternative splicing and muscular dystrophy. 5
Alternative Splicing and Tumor Progression 5
Splicing factor SF2/ASF controls cell motility by modulating alternative splicing of the Ron proto-oncogene 5
SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene 5
A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing 5
A single polypyrimidine tract binding protein (PTB) binding site mediates splicing inhibition at mouse IgM exons M1 and M2. 5
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in Cancer. 5
Aberrant alternative splicing: role in tumorigenesis and prospect for therapies 5
Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells 5
A 2-nt RNA enhancer on exon 11 promotes exon 11 inclusion of the Ron proto-oncogene. 5
SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene. 5
Nuclear stress bodies: anatomy and physiology of heterochromatin transcription factories. 4
Totale 500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.015
article - articoli 1.559
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 158
Totale 3.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20243 0 0 0 0 0 0 0 0 2 0 0 1
2024/2025497 7 2 78 33 276 99 2 0 0 0 0 0
Totale 500